BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 29
• 30

• Press Releases

  GenSight Biologics Announces Regulatory Approval for GS010/LUMEVOQ® REVISE Dose-Ranging Study in France

  December 3, 2025

   · 

  4 min read
• Press Releases

  Exousia Pro, Inc. Completes Exclusive Licensing Agreement With the University of Central Florida for Novel Cancer Diagnostic and Therapy Platforms

  December 3, 2025

   · 

  4 min read
• Press Releases

  Zymeworks Announces Participation in Upcoming Conferences - December 2, 2025

  December 3, 2025

   · 

  4 min read
• Press Releases

  Quetzal Therapeutics Launches Phase III Clinical Trial of Oral QTX-2101 for Acute Promyelocytic Leukemia (APL)

  December 3, 2025

   · 

  3 min read
• Press Releases

  ADC Therapeutics to Provide Update on LOTIS-7 Clinical Trial

  December 3, 2025

   · 

  5 min read
• Press Releases

  Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - December 2, 2025

  December 3, 2025

   · 

  2 min read
• Press Releases

  FibroGen to Present at the Oppenheimer Movers in Rare Disease Summit

  December 3, 2025

   · 

  1 min read
• Press Releases

  Curi Bio Secures $10M Series B to Scale Human-Relevant Preclinical Platforms and Advanced Data Analysis for Drug Discovery

  December 3, 2025

   · 

  4 min read
• Press Releases

  Unravel Biosciences Announces Approval by Colombian Health Regulatory Authority to Initiate RVL-001 Clinical Studies for Rett Syndrome and Pitt Hopkins Syndrome

  December 3, 2025

   · 

  2 min read
• Press Releases

  Archeus Technologies Doses First Patient with ART-101 in Phase 1 Prostate Cancer Study

  December 3, 2025

   · 

  4 min read